-
Archives
- June 2018
- February 2018
- May 2017
- January 2017
- December 2016
- November 2016
- October 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- August 2015
- July 2015
- June 2015
- March 2015
- February 2015
- September 2014
- July 2014
- January 2014
- November 2013
- July 2013
- June 2013
- April 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- June 2012
- May 2012
- March 2012
- December 2011
- November 2011
- July 2011
- March 2011
-
Meta
Tag Archives: AGAH
Exploratory medicines development – Innovation and risk management
First EUFEMED Conference Joint Meeting of European Human Pharmacological Societies Wednesday 17 May – Friday 19 May, 2017, London/UK Assessment and mitigation of risk are most challenging in exploratory drug development when a promising new compound is to be characterised … Continue reading
Comments Off on Exploratory medicines development – Innovation and risk management
AGAH Meeting, Berlin
AGAH, the German Association for Applied Human Pharmacology, held its 25th Annual Meeting on 21-22 April in Berlin, which focused on the topic “Exploratory drug development in immunological therapy”. The first day’s sessions covered a variety of immunological targets inherently … Continue reading
Comments Off on AGAH Meeting, Berlin
25th AGAH Annual Meeting 2016, Berlin
The Association for Applied Human Pharmacology / Arbeitsgemeinschaft für Angewandte Humanpharmakologie (AGAH) has provided further details of it’s 25th Annual Meeting that will be held this year in Berlin from 20-22 April. The topic of the meeting will be ‘Exploratory drug development … Continue reading
Comments Off on 25th AGAH Annual Meeting 2016, Berlin
Statement on the Recent Serious Adverse Events During a Clinical Trial in Europe
The European Federation for Exploratory Medicines Development (EUFEMED) yesterday posted a statement about the widely reported death and serious illnesses occurring in an exploratory clinical trial in Europe (link PRNewswire). EUFEMED is headquartered in Brussels and constitutes the federated member associations of … Continue reading
Comments Off on Statement on the Recent Serious Adverse Events During a Clinical Trial in Europe
Introductory Course on Human Pharmacology / Translational Medicine – Part II, Heidelberg (Germany), 13th – 15th February 2014
The AGAH board invite new and existing participants to the continuation of the November 2013 workshop. This course provides a basic training in Human Pharmacology and is addressed to postgraduates in life sciences interested in early clinical development of medicinal … Continue reading
Message from Chair: Presentations from the Joint Conference of European Human Pharmacological Societies
Dear Members, I have recently returned from a very successful and interesting International meeting in France held between the French (Club Phase 1), German (AGAH), Belgian (BAPU) and UK (AHPPI),human pharmacological societies. The meeting was entitled EARLY CLINICAL UTILITY ASSESSMENT … Continue reading